Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 1
2020 4
2021 8
2022 3
2023 11
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
AUTHOR REPLY.
Soerensen SJC, Thomas IC, Schmidt B, Daskivich TJ, Skolarus TA, Jackson C, Osborne TF, Chertow GM, Brooks JD, Rehkopf DH, Leppert JT. Soerensen SJC, et al. Among authors: osborne tf. Urology. 2021 Sep;155:76. doi: 10.1016/j.urology.2021.05.058. Urology. 2021. PMID: 34489006 No abstract available.
Effectiveness of COVID-19 Treatment With Nirmatrelvir-Ritonavir or Molnupiravir Among U.S. Veterans: Target Trial Emulation Studies With One-Month and Six-Month Outcomes.
Bajema KL, Berry K, Streja E, Rajeevan N, Li Y, Mutalik P, Yan L, Cunningham F, Hynes DM, Rowneki M, Bohnert A, Boyko EJ, Iwashyna TJ, Maciejewski ML, Osborne TF, Viglianti EM, Aslan M, Huang GD, Ioannou GN. Bajema KL, et al. Among authors: osborne tf. Ann Intern Med. 2023 Jun;176(6):807-816. doi: 10.7326/M22-3565. Epub 2023 Jun 6. Ann Intern Med. 2023. PMID: 37276589 Free PMC article. Clinical Trial.
Effectiveness of Nirmatrelvir-Ritonavir Against the Development of Post-COVID-19 Conditions Among U.S. Veterans : A Target Trial Emulation.
Ioannou GN, Berry K, Rajeevan N, Li Y, Mutalik P, Yan L, Bui D, Cunningham F, Hynes DM, Rowneki M, Bohnert A, Boyko EJ, Iwashyna TJ, Maciejewski ML, Osborne TF, Viglianti EM, Aslan M, Huang GD, Bajema KL. Ioannou GN, et al. Among authors: osborne tf. Ann Intern Med. 2023 Nov;176(11):1486-1497. doi: 10.7326/M23-1394. Epub 2023 Oct 31. Ann Intern Med. 2023. PMID: 37903369 Free PMC article.
Risk of Potentially Preventable Hospitalizations After SARS-CoV-2 Infection.
Govier DJ, Niederhausen M, Takata Y, Hickok A, Rowneki M, McCready H, Smith VA, Osborne TF, Boyko EJ, Ioannou GN, Maciejewski ML, Viglianti EM, Bohnert ASB, O'Hare AM, Iwashyna TJ, Hynes DM; US Department of Veterans Affairs Health Services Research and Development COVID-19 Observational Research Collaboratory. Govier DJ, et al. Among authors: osborne tf. JAMA Netw Open. 2024 Apr 1;7(4):e245786. doi: 10.1001/jamanetworkopen.2024.5786. JAMA Netw Open. 2024. PMID: 38598237 Free PMC article.
Use of deep learning to develop continuous-risk models for adverse event prediction from electronic health records.
Tomašev N, Harris N, Baur S, Mottram A, Glorot X, Rae JW, Zielinski M, Askham H, Saraiva A, Magliulo V, Meyer C, Ravuri S, Protsyuk I, Connell A, Hughes CO, Karthikesalingam A, Cornebise J, Montgomery H, Rees G, Laing C, Baker CR, Osborne TF, Reeves R, Hassabis D, King D, Suleyman M, Back T, Nielson C, Seneviratne MG, Ledsam JR, Mohamed S. Tomašev N, et al. Among authors: osborne tf. Nat Protoc. 2021 Jun;16(6):2765-2787. doi: 10.1038/s41596-021-00513-5. Epub 2021 May 5. Nat Protoc. 2021. PMID: 33953393
32 results